Rimonabant and Paracetamol and placebo
Drugevaluation of an possible inhibiting effect of rimonabant on the analgesic effect of paracetamol in healthy volunteers
NCT Number: NCT00750347
Evaluation of an possible inhibiting effect of Rimonabant on the analgesic effect of Paracetamol in healthy volunteers
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
CHU Clermont-Ferrand, Clermont-Ferrand, France
Double Blind, cross-over, randomized and controlled versus placebo, study in healthy volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
evaluation of an possible inhibiting effect of rimonabant on the analgesic effect of paracetamol in healthy volunteers
Time frame: during electrical stimulation
Time frame: with or without rimonabant
University Hospital, Clermont-Ferrand
Other
Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07335159
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT05733039
Agnosia, Expectations
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT03033589
Agnosia, Nervous System Diseases
Detroit, Michigan, United States
View Trial DetailsNCT06889870
Agnosia, Anesthesia
Itabira, Minas Gerais, Brazil
View Trial Details